Equillium Secures $50 Million Investment from Leading Healthcare Investors

Equillium secures substantial investment to develop innovative therapies for severe autoimmune and inflammatory disorders

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here